Building GMP-Ready DNA Manufacturing Infrastructure: Ensuring Quality, Consistency, &Scalability from R&D to Commercial Production
- Evolving facilities and quality systems as DNA transitions from a starting material to a GMP drug substance
- Developing technical depth and alignment across global, cross-functional teams to ensure consistent process performance
- Strengthening collaboration and knowledge exchange with CDMOs and suppliers to enable effective scale-up and seamless tech transfer from R&D to GMP